FIRECLAY HEALTH
BELLEVUE ROAD, ST GEORGE, BRISTOL
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 22 | 25 | 88.0% | |
| HF 4 | 2011 | 18 | 20 | 90.0% | |
| HF 4 | 2012 | 16 | 18 | 88.9% | |
| HF 4 | 2013 | 15 | 17 | 88.2% | |
| HF004 | 2014 | 8 | 8 | 100.0% | |
| HF004 | 2015 | 27 | 28 | 96.4% | |
| HF004 | 2016 | 31 | 32 | 96.9% | |
| HF004 | 2017 | 32 | 34 | 94.1% | |
| HF004 | 2018 | 31 | 34 | 91.2% | |
| HF004 | 2019 | 50 | 57 | 87.7% | |
| HF004 | 2020 | 47 | 52 | 90.4% | |
| HF006 | 2021 | 53 | 57 | 93.0% | |
| HF006 | 2022 | 55 | 56 | 98.2% | |
| HF006 | 2023 | 57 | 65 | 87.7% |
